Literature DB >> 22172376

Colorectal liver metastases rarely occur in patients with chronic hepatitis virus infection.

Feng-Shan Wang1, Zi-Gong Shao, Jia-Lin Zhang, Yong-Feng Liu.   

Abstract

BACKGROUND/AIMS: There are studies that report that liver metastases rarely occur in patients with cirrhosis. This study evaluates the relationship between the incidence of liver metastases from colorectal cancer (CRC) and chronic hepatitis virus infection in patients.
METHODOLOGY: Three hundred and fifty-four cases of advanced CRC from our hospital were evaluated. The patients were divided into a chronic hepatitis virus infection group and a non-hepatitis virus infection group. The two groups were compared regarding the incidence of colorectal liver metastases and survival. The criterion of colorectal liver metastases was based on liver CT examination and intraoperative exploration results.
RESULTS: There were two cases with colorectal liver metastases among the seventy cases of the chronic hepatitis virus infection group. The rate of liver metastases was 2.86%. There were 48 cases with colorectal liver metastases among 284 cases of the non-hepatitis virus infection. The rate of liver metastases was 16.9%. The incidence of colorectal liver metastases between the two groups was significantly different (p<0.01). Five-year survival rates were 60% and 40.8% in the chronic hepatitis virus infection group and the non-hepatitis virus infection group, respectively (p<0.05). The degree of progress in the two groups of patients showed no significant difference.
CONCLUSIONS: Colorectal liver metastases occur rarely with chronic hepatitis virus infection and the patients in our study had good prognoses.

Entities:  

Mesh:

Year:  2012        PMID: 22172376     DOI: 10.5754/hge11747

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

1.  Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial.

Authors:  Jiaming Zhou; Tuoyang Li; Yuanlv Xiao; Jinxin Lin; Xiaoqiong Chen; Shaoyong Peng; Mingzhe Huang; Xuebin Shi; Linbin Cai; Pinzhu Huang; Meijin Huang
Journal:  Ann Transl Med       Date:  2022-06

2.  Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis.

Authors:  Bin Cai; Kai Liao; Xian-qing Song; Wei-yuan Wei; Yuan Zhuang; Sen Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

3.  Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.

Authors:  Atsuo Kobayashi; Daisuke Morioka; Chizuru Matsumoto; Yasuhiko Miura; Masaru Miura
Journal:  J Med Case Rep       Date:  2016-05-27

4.  Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.

Authors:  Qiwen Chen; Zhouyu Ning; Lei Wang; Haifeng Ying; Shu Dong; Chenyue Zhang; Xiaoheng Shen; Yuanbiao Guo; Hao Chen; Xiaoyan Zhu; Yehua Shen; Weidong Shi; Yongqiang Hua; Kun Wang; Junhua Lin; Litao Xu; Lianyu Chen; Lanyun Feng; Xiumei Zhang; Jing Xie; Bo Sun; Yaqin Sun; Wenchao Gu; Mei Kang; Zheng Tang; Zhujun Chen; Zhen Chen; Luming Liu; Jinming Yu; Zhaoshen Li; Zhiqiang Meng
Journal:  Oncotarget       Date:  2016-12-20

5.  HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up.

Authors:  Jiaming Zhou; Xiaoyan Guo; Pinzhu Huang; Shuyun Tan; Rongwan Lin; Huanmiao Zhan; Xiaofeng Wu; Tuoyang Li; Mingzhe Huang; Meijin Huang
Journal:  Cancer Manag Res       Date:  2022-04-27       Impact factor: 3.602

Review 6.  The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Filippo Monelli; Giulia Besutti; Olivera Djuric; Laura Bonvicini; Roberto Farì; Stefano Bonfatti; Guido Ligabue; Maria Chiara Bassi; Angela Damato; Candida Bonelli; Carmine Pinto; Pierpaolo Pattacini; Paolo Giorgi Rossi
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

7.  The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer.

Authors:  Takayuki Kondo; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Kohei Shigeta; Yuko Kitagawa
Journal:  Br J Cancer       Date:  2016-06-09       Impact factor: 7.640

8.  FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.

Authors:  Felipe José Fernandez Coimbra; Heber Salvador de Castro Ribeiro; Márcio Carmona Marques; Paulo Herman; Rubens Chojniak; Antonio Nocchi Kalil; Evanius Garcia Wiermann; Sandro Roberto de Araújo Cavallero; Fabricio Ferreira Coelho; Paulo Henrique de Souza Fernandes; Anderson Arantes Silvestrini; Maria Fernanda Arruda Almeida; Antônio Luis Eiras de Araújo; Marcos Pitombo; Heberton Medeiros Teixeira; Fábio Luiz Waechter; Fábio Gonçalves Ferreira; Alessandro Landskron Diniz; Giuseppe D'Ippolito; Giuseppe D'Ippolito; Maria Dirlei F de Sousa Begnami; Gabriel Prolla; Silvio Márcio Pegoraro Balzan; Thiago Bueno de Oliveira; Luís Arnaldo Szultan; Javier Lendoire; Orlando Jorge Martins Torres
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

9.  Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation.

Authors:  Lipeng Cheng; Li Geng; Binghua Dai; Tao Zheng; Jun Fu; Liang Qiao; Wenchang Cai; Yue Wang; Jiamei Yang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

10.  Association between hepatitis B virus infection and colorectal liver metastasis: a meta-analysis.

Authors:  Rongqiang Liu; Weihao Kong; Mingbin Deng; Guozhen Lin; Tianxing Dai; Linsen Ye
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.